These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 199192)

  • 1. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin.
    Bhown AS; Habeerb AF
    Biochem Biophys Res Commun; 1977 Oct; 78(3):889-96. PubMed ID: 199192
    [No Abstract]   [Full Text] [Related]  

  • 2. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan content of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Infect Immun; 1985 Jan; 47(1):260-3. PubMed ID: 2856914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation.
    Worthington RW; Mülders MS
    Infect Immun; 1977 Nov; 18(2):549-51. PubMed ID: 200566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on epsilon-prototoxin of Clostridium perfringens type D. Physicochemical and chemical properties of epsilon-prototoxin.
    Habeeb AF
    Biochim Biophys Acta; 1975 Nov; 412(1):62-9. PubMed ID: 172146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of one tryptophan residue in the lethal activity of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Biochem Biophys Res Commun; 1985 Apr; 128(2):760-6. PubMed ID: 2859854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.
    Harkness JM; Li J; McClane BA
    Anaerobe; 2012 Oct; 18(5):546-52. PubMed ID: 22982043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.
    Freedman JC; Li J; Uzal FA; McClane BA
    mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system.
    Dorca-Arévalo J; Martín-Satué M; Blasi J
    Vet Microbiol; 2012 May; 157(1-2):179-89. PubMed ID: 22264388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of toxicity of Clostridium perfringens epsilon toxin.
    Bokori-Brown M; Savva CG; Fernandes da Costa SP; Naylor CE; Basak AK; Titball RW
    FEBS J; 2011 Dec; 278(23):4589-601. PubMed ID: 21518257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.
    Theoret JR; Li J; Navarro MA; Garcia JP; Uzal FA; McClane BA
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.
    Theoret JR; Uzal FA; McClane BA
    Infect Immun; 2015 Apr; 83(4):1477-86. PubMed ID: 25643999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of labeled Clostridium perfringens epsilon toxin in mice.
    Nagahama M; Sakurai J
    Toxicon; 1991; 29(2):211-7. PubMed ID: 2048139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.
    Habeeb AF
    Arch Biochem Biophys; 1969 Mar; 130(1):430-40. PubMed ID: 4305163
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON XI-PROTOTOXIN OF CLOSTRIDIUM PERFRINGENS TYPE D.
    HABEEB AF
    Can J Biochem; 1964 Apr; 42():545-54. PubMed ID: 14167002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.